Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation*

Although glucocorticoids suppress proliferation of many cell types and are used in the treatment of certain cancers, trials of glucocorticoid therapy in breast cancer have been a disappointment. Another suggestion that estrogens may affect glucocorticoid action is that the course of some inflammatory diseases tends to be more severe and less responsive to corticosteroid treatment in females. To date, the molecular mechanism of cross-talk between estrogens and glucocorticoids is poorly understood. Here we show that, in both MCF-7 and T47D breast cancer cells, estrogen inhibits glucocorticoid induction of the MKP-1 (mitogen-activated protein kinase phosphatase-1) and serum/glucocorticoid-regulated kinase genes. Estrogen did not affect glucocorticoid-induced glucocorticoid receptor (GR) nuclear translocation but reduced ligand-induced GR phosphorylation at Ser-211, which is associated with the active form of GR. We show that estrogen increases expression of protein phosphatase 5 (PP5), which mediates the dephosphorylation of GR at Ser-211. Gene knockdown of PP5 abolished the estrogen-mediated suppression of GR phosphorylation and induction of MKP-1 and serum/glucocorticoid-regulated kinase. More importantly, after PP5 knockdown estrogen-promoted cell proliferation was significantly suppressed by glucocorticoids. This study demonstrates cross-talk between estrogen-induced PP5 and GR action. It also reveals that PP5 inhibition may antagonize estrogen-promoted events in response to corticosteroid therapy.

[1]  V. Jordan,et al.  Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance. , 2008, Advances in experimental medicine and biology.

[2]  D. Edwards,et al.  The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression , 2008, Steroids.

[3]  S. Weiss,et al.  Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. , 2008, American journal of respiratory and critical care medicine.

[4]  Claudio N. Cavasotto,et al.  Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.

[5]  K. Kang,et al.  Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. , 2008, Chemico-biological interactions.

[6]  R. Samant,et al.  Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. , 2008, Biochimica et biophysica acta.

[7]  H. Chao,et al.  The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene. , 2008, Taiwanese journal of obstetrics & gynecology.

[8]  K. Blackwell,et al.  Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease. , 2008, Clinical breast cancer.

[9]  J. Nabholtz.  Long-term safety of aromatase inhibitors in the treatment of breast cancer , 2008, Therapeutics and clinical risk management.

[10]  R. Weinshilboum.  Pharmacogenomics of endocrine therapy in breast cancer. , 2008, Advances in experimental medicine and biology.

[11]  T. Hinds,et al.  Protein phosphatase 5. , 2008, The international journal of biochemistry & cell biology.

[12]  Bruce D Keith,et al.  Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy , 2008, BMC Cancer.

[13]  E. Kawasaki,et al.  Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. , 2007, Molecular endocrinology.

[14]  M. Garabedian,et al.  Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. , 2007, Molecular endocrinology.

[15]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[16]  J. Loffing,et al.  Sgk kinases and their role in epithelial transport. , 2006, Annual review of physiology.

[17]  M. Dowsett,et al.  Potential of endogenous estrogen receptor β to influence the selective ER modulator ERβ complex , 2005 .

[18]  Jen-kun Lin,et al.  Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. , 2005, Carcinogenesis.

[19]  Raj Kumar,et al.  p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. , 2005, Molecular endocrinology.

[20]  Raj Kumar,et al.  Gene regulation by the glucocorticoid receptor: Structure:function relationship , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  Andrew H. Miller,et al.  Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells , 2005, Neuropsychopharmacology.

[22]  D. Barford,et al.  Molecular basis for TPR domain‐mediated regulation of protein phosphatase 5 , 2005, The EMBO journal.

[23]  Qing Lu,et al.  Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Greene,et al.  Plasma membrane estrogen receptors exist and functions as dimers. , 2004, Molecular endocrinology.

[25]  N. Dean,et al.  Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice. , 2004, Cancer letters.

[26]  L. Ou,et al.  Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. , 2004, The Journal of allergy and clinical immunology.

[27]  Ye Zhang,et al.  Repression of hsp90β Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells* , 2004, Journal of Biological Chemistry.

[28]  E. Ciszak,et al.  Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5* , 2004, Journal of Biological Chemistry.

[29]  M. Garabedian,et al.  Modulation of Glucocorticoid Receptor Function via Phosphorylation , 2004, Annals of the New York Academy of Sciences.

[30]  K. Horie-Inoue,et al.  Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. , 2004, Molecular endocrinology.

[31]  A. Miller,et al.  Interleukin 1α (IL-1α) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function , 2004, Molecular Psychiatry.

[32]  M. Garabedian,et al.  Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1* , 2003, Journal of Biological Chemistry.

[33]  Heike Brand,et al.  Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.

[34]  H. Kinyamu,et al.  Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression , 2003, Molecular and Cellular Biology.

[35]  N. Dean,et al.  Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression* , 2003, The Journal of Biological Chemistry.

[36]  Jiahuai Han,et al.  Inhibition of p38 MAPK by Glucocorticoids via Induction of MAPK Phosphatase-1 Enhances Nontypeable Haemophilus influenzae-induced Expression of Toll-like Receptor 2* , 2002, The Journal of Biological Chemistry.

[37]  J. Saklatvala,et al.  Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38 , 2002, Molecular and Cellular Biology.

[38]  J. R. Campbell,et al.  Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5'-flanking region. , 2002, American journal of physiology. Endocrinology and metabolism.

[39]  O. Kassel,et al.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.

[40]  C. Kirschbaum,et al.  Sex Differences in Glucocorticoid Sensitivity of Proinflammatory Cytokine Production After Psychosocial Stress , 2001, Psychosomatic medicine.

[41]  E. Levin.  highlighted topics Genome and Hormones: Gender Differences in Physiology Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors , 2001 .

[42]  N. Dean,et al.  Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively* , 2001, The Journal of Biological Chemistry.

[43]  Suzanne D. Conzen,et al.  Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1 * , 2001, The Journal of Biological Chemistry.

[44]  B. Darimont,et al.  Novel glucocorticoid receptor coactivator effector mechanisms , 2001, Trends in Endocrinology & Metabolism.

[45]  D. Feldman,et al.  Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  M. Ross,et al.  Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[47]  E. Levin,et al.  Estrogen Signals to the Preservation of Endothelial Cell Form and Function* , 2000, The Journal of Biological Chemistry.

[48]  D. Agard,et al.  Oestrogen receptor function at classical and alternative response elements. , 2000, Novartis Foundation symposium.

[49]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  N. Dean,et al.  Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. , 1999, Biochemistry.

[51]  R. Sutherland,et al.  c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry , 1998, Molecular and Cellular Biology.

[52]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[53]  S. Logan,et al.  Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.

[55]  M. Galigniana,et al.  Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin* , 1997, The Journal of Biological Chemistry.

[56]  A. Silverstein,et al.  The Tetratricopeptide Repeat Domain of Protein Phosphatase 5 Mediates Binding to Glucocorticoid Receptor Heterocomplexes and Acts as a Dominant Negative Mutant* , 1996, The Journal of Biological Chemistry.

[57]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[58]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[59]  M. Gorospe,et al.  Role of Mitogen-activated Protein Kinase Phosphatase during the Cellular Response to Genotoxic Stress , 1995, The Journal of Biological Chemistry.

[60]  Hong Sun,et al.  MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.

[61]  Lin Chen,et al.  Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth , 1993, Molecular and cellular biology.

[62]  G. Firestone,et al.  Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase. , 1993, The Journal of biological chemistry.

[63]  M. Zelen,et al.  A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. , 1985, Cancer research.

[64]  W. McGuire,et al.  Steroid hormone receptors in breast cancer treatment strategy. , 1980, Recent progress in hormone research.